首页> 外文期刊>Leukemia Research Reports >Lymphocyte recovery and infused CD34+ cells dose: Effect on the evolution after stem cell autotransplantation
【24h】

Lymphocyte recovery and infused CD34+ cells dose: Effect on the evolution after stem cell autotransplantation

机译:淋巴细胞恢复和注入的CD34 +细胞剂量:对干细胞自体移植后进化的影响

获取原文
       

摘要

Background and objective The number of infused CD34+cells (CD34+ i ) has been associated with absolute lymphocyte count (ALC) and the outcome undergoing autologous hematopoietic stem cell transplantation (HSCT) in patients with hematologic malignancies. The study's aim was to analyze the relationship between CD34+ i , ALC and prognosis in this patients. Patients and method Medical records of 163 patients receiving HSCT between 2005 and 2012 were reviewed. Results We found significant and inversely proportional relationship between the CD34+ i and the days required to reach ALC≥500/μl according to the regression line: days=?0.981×number of CD34+ i +18.09. Conclusions We have obtained a predictive model of lymphocyte recovery based recovery of CD34+ i .
机译:背景和目的血液系统恶性肿瘤患者中,注入的CD34 +细胞(CD34 + i)的数量与绝对淋巴细胞计数(ALC)和进行自体造血干细胞移植(HSCT)的结局有关。该研究的目的是分析该患者中CD34 + i,ALC与预后之间的关系。患者和方法回顾了2005年至2012年间163例接受HSCT的患者的病历。结果根据回归线,我们发现CD34 + i与达到ALC≥500/μl所需的天数之间存在显着的反比例关系:天数=?0.981×CD34 + i数+18.09。结论我们已经获得了基于CD34 + i恢复的淋巴细胞恢复的预测模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号